Organ dysfunction in advanced melanoma patients treated with immune checkpoint inhibitors

Spillane, S, Baxi, SS, Torres, AZ, Lenis, D, Freedman, AN, Mariotto, A

July 2020

Manuscript

The Oncologist

Flatiron-authored

The adoption of immune checkpoint inhibitors and patterns of care at the end of life

Riaz, F, Gan, G, Li, F, Davidoff, AJ, Adelson, KB, Presley, CJ, Adamson, BJS, Shaw, P, Parikh, RB, Mamtani, R, Gross, CP

July 2020

Manuscript

JCO Oncology Practice

Flatiron-authored

July 2020

Manuscript

The Oncologist

June 2020

Manuscript

Advances in Therapy

June 2020

Manuscript

JAMA Open

Flatiron-authored

Evaluating the impact of oncology care model reporting requirements on biomarker testing and treatment

Castellanos, EH, Orlando, A, Ma, X, Parikh, RB, O'Connell, G, Meropol, NJ, Hamrick, HJ, Adamson, BJS

June 2020

Manuscript

Journal of Oncology Practice

Flatiron-authored

Clinical and genomic characteristics of small-cell lung cancer in never-smokers

Thomas, A, Mian, I, Tlemsani, C, Pongor, L, Takahashi, N, Maignan, K, Snider, J, Li, G, Frampton, GM, Ali, SM, Kim, S, Nichols, S, Rajapakse, V, Guha, U, Sharon, E, Fujimoto, J, Moran, CA, Witstuba, II, Wei, JS, Szabo, E, Torres, AZ, Carson, KR

May 2020

Manuscript

Chest

Flatiron-authored

Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agents

Giri, S, Huntington, SF, Wang, R, Zeidan, AM, Podoltsev, NA, Gore, SD, Ma, X, Gross, CP, Davidoff, AJ, Neparidze, N

May 2020

Manuscript

Blood Advances

May 2020

Manuscript

Journal of Oncology Pharmacy Practice

May 2020

Manuscript

Clinical Lymphoma; Myeloma; and Leukemia

May 2020

Abstract

AACR Annual Meeting

Flatiron-authored

Identification of genomic alterations related to treatment progression in RWD

Chaudhary, N, Luhn, P, Jansen, G, Metcalfe, C, Hafner, M

May 2020

Abstract

AACR Annual Meeting

May 2020

Abstract

AACR Annual Meeting

May 2020

Abstract

AACR Annual Meeting

Characterization and potential therapeutic implications of SMARCA4 variants revealed by targeted exome-sequencing of 131668 cancer patients

Fernando, TM, Piskol, R, Bainer, R, Sokol, ES, Trabucco, SE, Zhang, Q, Trinh, H, Maund, SL, Kschonsak, M, Chaudhuri, S, Modrusan, Z, Januario, T, Modrusan, Z, Yauch, RL

May 2020

Abstract

AACR Annual Meeting

May 2020

Manuscript

Future Oncology

Characteristics and outcomes of real-world patients with microsatellite instability-high solid tumors treated with pembrolizumab monotherapy after FDA approval

Snow, T, Swaminathan, A, Snider, J, Schrock, AB, Li, G, Alexander, BM, Singal, G, Castellanos, EH, McCusker, M

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

Association of BRCA alteration type with real-world outcomes to PARP inhibitors in patients with metastatic castrate-resistant prostate cancer

Antonarakis, ES, Madison, RW, Snider, J, Snow, T, Sokol, ES, Chung, JH, McCusker, M, Singal, G, Alexander, BM, Castellanos, EH, Venstrom, JM, Schrock, AB, Ross, JS

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

An automated EHR-based tool for identification of patients with metastatic disease to facilitate clinical trial patient ascertainment

Kirshner, J, Cohn, K, Dunder, Steven, Donahue, K, Richey, MM, Larson, PD, Sutton, LM, Siu, E, Donegan, J, Chen, Z, Nightingale, C, Hamrick, HJ

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

Use of real-world data to understand barriers to interventional clinical trial enrollment in community oncology clinics

Blakely, J, Gordon, L, Schwartzberg, L, Gutman, J, Adamson, BJS, Bourla, AB, Meropol, NJ, Ramsey, SD, Green, RJ

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

A multi-stakeholder platform to prospectively link longitudinal real-world clinico-genomic, imaging, and outcomes data for patients with metastatic lung cancer

Lu, MW, Walia, G, Schulze, K, Doral, MY, Maund, SL, Gaffey, S, Cabili, MN, Bourla, AB, Green, RJ, Santos, EC, Herbst, RS, Chiang, AC, Schwartzberg, L

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

The adoption of immune checkpoint inhibitors and patterns of care at the end of life

Riaz, F, Gan, G, Li, F, Davidoff, AJ, Adelson, KB, Presley, CJ, Adamson, BJS, Shaw, P, Parikh, RB, Mamtani, R, Gross, CP

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

Real-world outcomes for advanced non-small cell lung cancer patients with EGFR exon 19 deletions stratified by deletion size

Ou, SI, Madison, RW, Snow, T, Snider, J, McCusker, M, Singal, G, Alexander, BM, Venstrom, JM, Castellanos, EH, Schrock, AB

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Real-world ALK testing compliance to NCCN guideline and factors of underutilization

Bernicker, E, Xiao, Y, Abraham, A, Engstrom-Melnyk, J, Croix, D, Yang, B, Shah, RA, Madala, J, Allen, T

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Real-world outcomes of patients with BRAF-mutated mCRC treated in the United States

Braithwaite, M, Nevala-Plagemann, C, Baron, K, Halland, B, Garrido-Laguna, I, Pappas, LM, Moser, JC

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Real-world outcomes after second-line treatment in non-small cell lung cancer patients treated with immunotherapy

Marmarelis, ME, Hwang, W-T, Yang, Y-X, Ciunci, C, Singh, A, Aggarwal, C, Cohen, RB, Langer, CJ, Mamtani, R, Bauml, JM

May 2020

Abstract

ASCO Annual Meeting

Prevalence of ALK mutation in advanced NSCLC patients in the United States

Allen, T, Xiao, Y, Abraham, A, Redpath, S, Engstrom-Melnyk, J, Croix, D, Yang, B, Shah, RA, Madala, J, Bernicker, E

May 2020

Abstract

ASCO Annual Meeting

Uptake of targeted therapy in clinical practice among US patients with ovarian cancer

Chan, J, Meyer, L, Luhn, P, Flores, C, Bastere-Truchot, L, Downer, MK, Lin, YG, Wright, JD

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Indirect comparison of TAK-788 vs real-world data outcomes in refractory non-small cell lung cancer with EGFR exon 20 insertions

Horn, L, Lin, HM, Padda, SK, Aggarwal, C, McCoach, CE, Zhu, Y, Yin, Y, Li, S, Feng, Z, Neal, JW

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Real-world treatment patterns and clinical outcomes of advanced melanoma patients following disease progression on anti-PD-1-based therapy

Hernandez-Aya, LF, Burke, M, Collins, JM, Earle, D, Hamilton, M, Nordstrom, BL, Zhang, Y, Srivastava, S

May 2020

Abstract

ASCO Annual Meeting

Uptake of first-line immune checkpoint inhibitors among medically frail patients with advanced solid malignancies

Parikh, RB, Cohen, RB, Min, EJ, Wileyto, EP, Riaz, F, Gross, CP, Long, Q, Mamtani, R

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting